{
    "clinical_study": {
        "@rank": "82377", 
        "arm_group": [
            {
                "arm_group_label": "PVI+LL", 
                "arm_group_type": "Active Comparator", 
                "description": "Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium."
            }, 
            {
                "arm_group_label": "PVI+LL+BT injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.\nInjection of the botulinum toxin is performed in main anatomical zones of ganglionated plexuses of left atrium using Myostar catheter (Biosense Webster)."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators have conducted a prospective, double-blind, randomized study to assess the\n      comparative safety and efficacy of two different ablation strategies, PVI plus linear\n      lesions (LL) plus botulinum toxin injection versus PVI plus linear lesions (LL), in patients\n      with persistent or longstanding persistent AF. Results were assessed with the use of an\n      implanted monitoring device (IMD)."
        }, 
        "brief_title": "Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Persistent Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Persistent and longstanding persistent AF\n\n        Exclusion Criteria:\n\n          -  congestive heart failure\n\n          -  LV ejection fraction < 35%\n\n          -  left atrial diameter > 60 mm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008448", 
            "org_study_id": "BT_AFPers"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "PVI+LL", 
                    "PVI+LL+BT injection"
                ], 
                "intervention_name": "Pulmonary vein isolation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "PVI+LL", 
                    "PVI+LL+BT injection"
                ], 
                "intervention_name": "Linear Lesion Ablation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "PVI+LL+BT injection", 
                "intervention_name": "BT injection", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Botulinum Toxins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "link": {
            "description": "State Research Institute of Circulation Pathology Official Site", 
            "url": "http://meshalkin.ru"
        }, 
        "location": [
            {
                "contact": {
                    "email": "jss7@columbia.edu", 
                    "last_name": "Jonathan S. Steinberg, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11528"
                    }, 
                    "name": "The Valley Health System and Columbia University College of Physicians & Surgeons"
                }, 
                "investigator": {
                    "last_name": "Jonathan S. Steinberg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "E.Pokushalov@gmail.com", 
                    "last_name": "Evgeny Pokushalov, MD, PhD", 
                    "phone": "+79139254858"
                }, 
                "facility": {
                    "address": {
                        "city": "Novosibirsk", 
                        "country": "Russian Federation", 
                        "zip": "630055"
                    }, 
                    "name": "State Research Institute of Circulation Pathology"
                }, 
                "investigator": {
                    "last_name": "Evgeny Pokushalov, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Russian Federation"
            ]
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "e.pokushalov@gmail.com", 
            "last_name": "Evgeny Pokushalov, MD, PhD", 
            "phone": "+79139254858"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "freedom of atrial tachyarrhythmia, including AF and atrial flutter/tachycardia", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008448"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "serious adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "Meshalkin Research Institute of Pathology of Circulation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meshalkin Research Institute of Pathology of Circulation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}